Moderna, Inc. earnings per share and revenue

MRNA earnings per share for the last quarter are -3.33 USD whereas the estimation was -3.35 USD which accounts for 0.54% surprise. Company revenue for the same period amounts to 241.00 M USD despite the estimated figure of 128.41 M USD. Estimated earnings per share for the next quarter are -1.85 USD, and revenue is expected to reach 1.26 B USD. Also watch annual changes over time to get a bigger picture of MRNA earnings per share and revenue dynamics.